KWM
HQL

Kingsview Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

Kingsview Wealth Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$715K Hold
35,716
– – 0.01% 854
2026
Q1 		$581K Sell
35,716
-158
-0.4% -$2.64K 0.01% 848
2025
Q4 		$602K Hold
35,874
– – 0.01% 788
2025
Q3 		$556K Sell
35,874
-869
-2% -$11.9K 0.01% 772
2025
Q2 		$471K Buy
36,743
+1,000
+3% +$12.3K 0.01% 787
2025
Q1 		$454K Buy
35,743
+1,060
+3% +$14.4K 0.01% 757
2024
Q4 		$455K Sell
34,683
-271
-0.8% -$3.91K 0.01% 775
2024
Q3 		$527K Hold
34,954
– – 0.01% 699
2024
Q2 		$495K Sell
34,954
-1,020
-3% -$13.8K 0.01% 688
2024
Q1 		$490K Sell
35,974
-963
-3% -$13.3K 0.01% 668
2023
Q4 		$497K Buy
36,937
+904
+3% +$11.1K 0.01% 637
2023
Q3 		$449K Sell
36,033
-654
-2% -$8.6K 0.02% 643
2023
Q2 		$497K Sell
36,687
-471
-1% -$6.5K 0.02% 590
2023
Q1 		$518K Hold
37,158
– – 0.02% 565
2022
Q4 		$528K Hold
37,158
– – 0.02% 494
2022
Q3 		$508K Buy
37,158
+1,008
+3% +$15.1K 0.02% 500
2022
Q2 		$514K Buy
36,150
+1,921
+6% +$29K 0.02% 530
2022
Q1 		$566K Buy
34,229
+1,579
+5% +$27.2K 0.02% 542
2021
Q4 		$628K Buy
32,650
+2,489
+8% +$50.1K 0.03% 517
2021
Q3 		$627K Buy
30,161
+1,890
+7% +$40.5K 0.03% 491
2021
Q2 		$610K Buy
28,271
+13,945
+97% +$282K 0.03% 509
2021
Q1 		$288K Buy
+14,326
New +$295K 0.02% 658

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Kingsview Wealth Management's HQL Position: Q2 2026 in Review

Kingsview Wealth Management held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 35,716 shares worth $715K. The position accounts for 0.01% of the portfolio, ranked #854.

Kingsview Wealth Management first reported a position in HQL in Q1 2021 and has held it in 22 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Kingsview Wealth Management held 35,716 shares of abrdn Life Sciences Investors worth $715K as of Q2 2026.
  • Kingsview Wealth Management left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
  • abrdn Life Sciences Investors made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #854 holding.
  • Kingsview Wealth Management first reported a position in abrdn Life Sciences Investors in Q1 2021 and has held it in 22 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.